Kilian, M., Sheinin, R., Tan, C. L., Friedrich, M., Krämer, C., Kaminitz, A., . . . Platten, M. (2023). MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors. Cancer cell, 41(2), . https://doi.org/10.1016/j.ccell.2022.12.007
Chicago-Zitierstil (17. Ausg.)Kilian, Michael, et al. "MHC Class II-restricted Antigen Presentation Is Required to Prevent Dysfunction of Cytotoxic T Cells by Blood-borne Myeloids in Brain Tumors." Cancer Cell 41, no. 2 (2023). https://doi.org/10.1016/j.ccell.2022.12.007.
MLA-Zitierstil (9. Ausg.)Kilian, Michael, et al. "MHC Class II-restricted Antigen Presentation Is Required to Prevent Dysfunction of Cytotoxic T Cells by Blood-borne Myeloids in Brain Tumors." Cancer Cell, vol. 41, no. 2, 2023, https://doi.org/10.1016/j.ccell.2022.12.007.